Cargando…

Aberrant expression of nuclear HDAC3 and cytoplasmic CDH1 predict a poor prognosis for patients with pancreatic cancer

Previous studies showed that aberrant CDH1 or/and HDAC3 localization is essential for the progression of some human cancers. Here, we investigate the prognostic significance of aberrant CDH1 and HDAC3 localization in 84 pancreatic cancer patients. Our results show that increases in both membrane and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiao, Feng, Hu, Hai, Han, Ting, Zhuo, Meng, Yuan, Cuncun, Yang, Haiyan, Wang, Lei, Wang, Liwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941331/ https://www.ncbi.nlm.nih.gov/pubmed/26918727 http://dx.doi.org/10.18632/oncotarget.7663

Ejemplares similares

A novel feedback loop between high MALAT-1 and low miR-200c-3p promotes cell migration and invasion in pancreatic ductal adenocarcinoma and is predictive of poor prognosis
por: Zhuo, Meng, et al.
Publicado: (2018)

Coordinated silencing of the Sp1-mediated long noncoding RNA MEG3 by EZH2 and HDAC3 as a prognostic factor in pancreatic ductal adenocarcinoma
por: Han, Ting, et al.
Publicado: (2020)

Sp1 and COX2 expression is positively correlated with a poor prognosis in pancreatic ductal adenocarcinoma
por: Hang, Junjie, et al.
Publicado: (2016)

Caveolin-2 is regulated by BRD4 and contributes to cell growth in pancreatic cancer
por: Jiao, Feng, et al.
Publicado: (2020)

Differential Effect of HDAC3 on Cytoplasmic and Nuclear Huntingtin Aggregates
por: Mano, Tatsuo, et al.
Publicado: (2014)

Long Noncoding RNA MALAT-1 Enhances Stem Cell-Like Phenotypes in Pancreatic Cancer Cells
por: Jiao, Feng, et al.
Publicado: (2015)

High HDAC9 is associated with poor prognosis and promotes malignant progression in pancreatic ductal adenocarcinoma
por: Li, He, et al.
Publicado: (2020)

HDAC10 Is Positively Associated With PD-L1 Expression and Poor Prognosis in Patients With NSCLC
por: Liu, Xiaomei, et al.
Publicado: (2020)

Aberrant FAM64A mRNA expression is an independent predictor of poor survival in pancreatic cancer
por: Jiao, Yan, et al.
Publicado: (2019)

Correlated high expression of FXR and Sp1 in cancer cells confers a poor prognosis for pancreatic cancer: A study based on TCGA and tissue microarray
por: Hu, Hai, et al.
Publicado: (2017)

Elevated COX-2 Expression Promotes Angiogenesis Through EGFR/p38-MAPK/Sp1-Dependent Signalling in Pancreatic Cancer
por: Hu, Hai, et al.
Publicado: (2017)

Aberrant methylation of CDH13 can be a diagnostic biomarker for lung adenocarcinoma
por: Pu, Weilin, et al.
Publicado: (2016)

Decreased expression of CDH1 or CTNNB1 affects poor prognosis of patients with esophageal cancer
por: Ishiguro, Hideyuki, et al.
Publicado: (2016)

High nuclear/cytoplasmic ratio of Cdk1 expression predicts poor prognosis in colorectal cancer patients
por: Sung, Wen-Wei, et al.
Publicado: (2014)

Aberrant expression of STYK1 and E-cadherin confer a poor prognosis for pancreatic cancer patients
por: Chen, Luguang, et al.
Publicado: (2017)

Histone deacetylase inhibitors inhibit lung adenocarcinoma metastasis via HDAC2/YY1 mediated downregulation of Cdh1
por: Wang, Dongmei, et al.
Publicado: (2023)

Heterogeneous nuclear ribonucleoprotein K is over expressed, aberrantly localised and is associated with poor prognosis in colorectal cancer
por: Carpenter, B, et al.
Publicado: (2006)

Aberrant expression of KPNA2 is associated with a poor prognosis and contributes to OCT4 nuclear transportation in bladder cancer
por: Zhou, Jingcheng, et al.
Publicado: (2016)

Distinct Impairments Characterizing Different ADNP Mutants Reveal Aberrant Cytoplasmic-Nuclear Crosstalk
por: Ganaiem, Maram, et al.
Publicado: (2022)

Cytoplasmic Kaiso is associated with poor prognosis in non-small cell lung cancer
por: Dai, Shun-Dong, et al.
Publicado: (2009)

Overexpression of HDAC9 is associated with poor prognosis and tumor progression of breast cancer in Chinese females
por: Huang, Yixiang, et al.
Publicado: (2018)

Data on the function of CDH17 in pancreatic cancer growth
por: Yuan, Hao, et al.
Publicado: (2019)

Correlations of Promoter Methylation in WIF-1, RASSF1A, and CDH13 Genes with the Risk and Prognosis of Esophageal Cancer
por: Guo, Qiang, et al.
Publicado: (2016)

KPNA2 is a nuclear export protein that contributes to aberrant localisation of key proteins and poor prognosis of breast cancer
por: Alshareeda, A T, et al.
Publicado: (2015)

Cytoplasmic and/or Nuclear Expression of β-Catenin Correlate with Poor Prognosis and Unfavorable Clinicopathological Factors in Hepatocellular Carcinoma: A Meta-Analysis
por: Chen, Jiang, et al.
Publicado: (2014)

Aberrant ARMCX1 Expression Is an Independent Predictor of Poor Prognosis in Gastric Cancer
por: Xie, Aosi, et al.
Publicado: (2022)

Single-cell analysis of pancreatic ductal adenocarcinoma identifies a novel fibroblast subtype associated with poor prognosis but better immunotherapy response
por: Wang, Yu, et al.
Publicado: (2021)

High HDAC5 expression correlates with a poor prognosis and the tumor immune microenvironment in gastric cancer
por: Yuan, Li, et al.
Publicado: (2022)

Nuclear accumulation of CDH1 mRNA in hepatocellular carcinoma cells
por: Ghafoory, S, et al.
Publicado: (2015)

Cytoplasmic maspin expression predicts poor prognosis of patients with soft tissue sarcomas
por: Takeda, Chikako, et al.
Publicado: (2014)

CDH13 promoter region is specifically methylated in poorly differentiated colorectal cancer
por: Hibi, K, et al.
Publicado: (2004)

Influence of HRH2 promoter polymorphism on aberrant DNA methylation of DAPK and CDH1 in the gastric epithelium
por: Nomura, Tomoe, et al.
Publicado: (2013)

HDACs/mTOR inhibitor synergizes with pyrotinib in HER2-positive pancreatic cancer through degradation of mutant P53
por: Mao, Tiebo, et al.
Publicado: (2022)

An HDAC in the Cytoplasm, not the Nucleus, Plays a Pathogenic Role in Huntington's Disease
por: Robinson, Richard
Publicado: (2013)

High cytoplasmic YAP1 expression predicts a poor prognosis in patients with colorectal cancer
por: Dong, Tianqi, et al.
Publicado: (2020)

Cytoplasmic SQSTM1/ P62 Accumulation Predicates a Poor Prognosis in Patients with Malignant Tumor
por: Zhu, Linhai, et al.
Publicado: (2018)

Aberrant HDAC3 expression correlates with brain metastasis in breast cancer patients
por: Ma, Li, et al.
Publicado: (2020)

Methylation silencing CDH23 is a poor prognostic marker in diffuse large B-cell lymphoma
por: Cao, Baoping, et al.
Publicado: (2021)

Validation of cytoplasmic-to-nuclear ratio of survivin as an indicator of improved prognosis in breast cancer
por: Rexhepaj, Elton, et al.
Publicado: (2010)

EZH2 promotes cell migration and invasion but not alters cell proliferation by suppressing E-cadherin, partly through association with MALAT-1 in pancreatic cancer
por: Han, Ting, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_3g2mo212tvg8uvfp14j9bsrmek